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Continuous-Flow Hydrogenation and Reductive
Deuteration of Nitriles: a Simple Access to α,α-Dideutero
Amines
Rebeka Mészáros,[a] Bai-Jing Peng,[a, b] Sándor B. Ötvös,[a, c, d] Shyh-Chyun Yang,[b, e, f] and
Ferenc Fülöp*[a, c]
A simple and efficient continuous flow methodology has been
developed for hydrogenation and reductive deuteration of
nitriles to yield primary amines and also valuable α,α-dideutero
analogues. Raney nickel proved to be a useful catalyst for the
transformation of a wide range of nitriles under reasonably mild
conditions with excellent deuterium incorporation (>90%) and
quantitative conversion. Among known model compounds,
three new deuterated primary amines were prepared. The
large-scale synthesis of deuterated tryptamine was also carried
out to deliver 1.1 g product under flow conditions.
The exchange of a hydrogen atom for deuterium in a drug
candidate molecule may improve its pharmacological profile.[1]
This is nicely exemplified by Austedo®, the first deuterated drug
marketed and also by numerous further representatives in
various clinical trials.[2] Given the importance of deuterated
drugs, much effort has been undertaken to develop suitable
methods for deuteration.[3] In many cases, deuterium-containing
materials are synthesized utilizing environmentally harmful and
costly deuterium sources,[4] such as LiAlD4 or NaBD4.
[5] Thus,
developing sustainable, inexpensive and simple methods can
be crucial in this area. In H/D exchange reactions induced by
heterogeneous metal catalysts, the most commonly used
deuterium sources are D2O, deuterated protic solvents and
gaseous deuterium.[6] In such reactions, the most widely used
combinations of catalysts and deuterium sources are
PtO2  D2  D2O,
[7] Pd/C  D2
[8] and Rh/SiO2  D2.
[9]
Amines have a pivotal role in synthetic organic chemistry
and they are widely present in pharmaceutical drugs and
bioactive natural products and are frequently used in medicinal
chemistry.[10] Various methods have been developed to trans-
form nitriles to amines, including metal hydride reductions,[11]
catalytic hydrogenations[12] and dissolving metal reductions.[13]
Of these, catalytic hydrogenation is applied the most frequently.
It is also the method of choice for the preparation of varied
amines in industry. Hydrogenation of nitriles is generally
performed in the presence of heterogeneous transition metal
catalysts, such as nickel, cobalt, palladium or platinum.[14]
Deuterated amines are relevant building blocks in the field
of drugs, deuterium labelled probes and functional materials.[15]
however their synthesis is relatively rare in the literature. An
important strategy to prepare deuterated amines is transfer
deuteration.[16] This method can be applied in the reductive
amination of ketones or aldehydes in D2O. Preformed imines
can also undergo transfer deuteration in D2O. These ap-
proaches, however, have several drawbacks. For example, only
low degrees of deuterium incorporations were observed.[16]
From an environmental and industrial point of view, reductive
deuteration of nitriles is an attractive strategy and valuable
transformation for the synthesis of deuterated amines. An
intriguing example was reported by An and co-workers. They
exploited sodium-mediated electron transfer reactions for the
synthesis of α,α-dideutero amines in the presence sodium
dispersions in EtOD  d1.[15a]
Conventional deuterium labelling techniques involve seri-
ous difficulties. For example, D2 gas as a deuterium source has
high cost and imposes additional operational challenges.[4]
Catalytic H  D exchange reactions often require long reaction
times, and alternatively, the costs of deuterated reagents and
deuterated solvents as isotopic sources severely limit the
practical applicability.[17] Therefore, our research group estab-
lished an individual flow-chemistry-based method for deutera-
tion reactions by exchanging the hydrogen source to deuter-
ated water in an H-Cube® system.[18] In fact, heterogeneous
catalytic hydrogenations and deuterations can achieve impor-
tant benefits from the features of flow chemistry,[19] especially
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through the unprecedented level of control over the most
important reaction conditions, the enhanced heat and mass
transfer, and the improved mixing properties.[20] However, in
terms of safety the application of the H-Cube® system provides
further advantages for lab-scale hydrogenations/deuterations as
H2 or D2 gas is generated in situ by electrolysis.
[21]
Herein, we report a simple and sustainable method for the
hydrogenation and reductive deuteration of nitriles producing
primary amines and valuable α,α-dideutero analogues in a
continuous-flow system with Raney nickel as heterogeneous
catalyst.
Hydrogenation and reductive deuteration reactions were
performed in an H-Cube® flow system, where the hydrogen
source (H2O) was changed to D2O in the case of deuterations.
The schematic representation of the reactor is shown in
Figure 1. Raney nickel catalyst was charged into a stainless steel
column, which ensured excellent ease of use. To avoid D  H
exchange and to maximize deuterium incorporation in the
reductive deuterations the use of an aprotic medium was
necessary. Therefore, the reactions were carried out in EtOAc as
solvent.
Our investigation was started by optimizing reaction
conditions of nitrile reduction to primary amines using 4-
phenylbutyronitrile as the model compound (Table 1). In this
reaction, two key parameters – temperature and pressure –
were optimized at a fixed flow rate of 1 mL/min. At 20 and
40 °C, practically no product formation was observed, while full
conversion was detected at 60 °C and 80 °C (entries 1–4). As for
the pressure, an efficient reaction required the use of at least
40 bar, because at lower pressure the conversion was merely
51% (entries 5–8). Consequently, the optimal parameters of the
reduction of 4-phenylbutyronitrile were 40 bar pressure and a
temperature of 60 °C affording quantitative conversion and a
selectivity of >99%.
After the successful optimization of synthesis parameters,
we investigated the reaction scope. A wide range of substituted
aliphatic and aromatic nitriles were tested under optimum flow
conditions (Table 2). Quantitative conversions and selectivity
values of >99% were observed for aromatic nitriles with
electron-donating or electron-withdrawing functional groups
Figure 1. Schematic outline of the continuous-flow reactor (H-Cube®).
Table 1. Optimization of reaction conditions for the hydrogenation of 4-
phenylbutyronitrile.
Entry p [bar] T [°C] Conversion [%][a] Selectivity [%][a]
1 40 20 0 –
2 40 40 traces –
3 40 60 100 >99
4 40 80 100 >99
5 20 60 51 >99
6 40 60 100 >99
7 60 60 100 >99
8 80 60 100 >99
[a] Determined by 1H NMR analysis of the crude product.
Table 2. Hydrogenation of diversely substituted aliphatic and aromatic
nitriles to primary amines under optimized flow conditions.
Entry Starting material Product Conv.
[%][a]
Sel.
[%][a]
1 100 >99
2 100 >99
3 100 >99
4 100 >99
5 100 >99
6 100 >99
7 100 >99
8 100 >99
9 100 >99
10 100 >99
[a] Determined by 1H NMR analysis of the crude product.
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(entries 1 and 2). Similarly good results were found for linear or
branched aliphatic nitriles bearing various substituents includ-
ing (hetero)aromatic rings (entries 3–7). Nitriles with bulky
substituents, such as adamantane-1-carbonitrile and diphenyla-
cetonitrile, were also nicely tolerated (entries 8 and 9). 3-(1-
Piperidinyl)propanenitrile was successfully transformed into the
corresponding amine (entry 10), yielding a significant intermedi-
ate for the synthesis of pharmaceutically relevant ω-piperidi-
noalkanamine derivatives with fluorescent moieties.[22]
After successful hydrogenation experiments, we next turned
our attention to continuous flow reductive deuterations to
access α,α-dideutero amines. For this, the hydrogen source in
the H-Cube® reactor was simply changed to D2O, and reaction
conditions optimized earlier for the hydrogenations were
utilized without any change (p=40 bar, T=60 °C, 1 mL/min
flow rate, Raney nickel as catalyst, EtOAc as solvent).
Excellent deuterium incorporations, quantitative conver-
sions and high selectivities were observed for a wide variety of
nitriles in their reduction to the corresponding α,α-dideutero
amines (Table 3). The reaction was successful for aromatic
nitriles possessing electron-donating or electron-withdrawing
functional groups (entries 1 and 2), and as well as for diversely
substituted aliphatic nitriles (entries 3–10), including adaman-
tane-1-carbonitrile and diphenylacetonitrile (entry 8 and 9).
Deuterated amines in Table 3 entries 8, 9 and 10, are new
materials, not known in the literature.
Finally, we investigated the applicability of the continuous
flow reductive deuteration method for the gram-scale synthesis
of deuterated tryptamine (Scheme 1). Tryptamine is a pharma-
ceutically active compound, found in trace amounts in the brain
of mammals and it is believed to play a significant role as
neurotransmitter or neuromodulator in the brain.[23] Samples
were taken and conversion and selectivity were determined in
every hour to obtain a clear view of catalyst activity (Figure S1
in the Supporting Information). We were delighted to find that
the Raney nickel catalyst worked for 20 hours without loss of
activity and change in selectivity during this time. Deuterated
tryptamine was formed with quantitative conversion, >99%
chemoselectivity and deuterium incorporation ratios of �95%
in all samples investigated. In the scale-out experiment, we
managed to produce 1.1 g of the deuterated product which
corresponded to an isolated yield of 92%.
A novel continuous-flow method has been developed for
hydrogenation and reductive deuteration of nitriles with Raney
nickel catalyst under mild conditions. The applicability of the
reactions was demonstrated with a wide range of nitriles with
varied substitution patterns affording outstanding conversions,
selectivities and deuterium incorporations. Importantly, valua-
ble α,α-dideutero amines were achieved in a simple, safe and
sustainable manner utilizing heterogenous catalysis, EtOAc as
environmentally-benign solvent and D2O as electrolytic deute-
rium source. The preparative capabilities of the synthesis
method were tested with a large-scale deuteration experiment
producing 1.1 gram of deuterated tryptamine. Acknowledgements
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2 100 >99
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7 100 95
8 100 96
9 100 98
10 100 90
[a] Chemoselectivity was >99% in all reactions. [b] Determined by 1H NMR
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incorporation rate over incidental hydrogenation).
Scheme 1. Gram-scale synthesis of deuterated tryptamine under flow
conditions.
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